IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
1.620
+0.046 (2.92%)
Aug 13, 2026, 5:29 PM CET
Revenue by Segment
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.